Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms

Chest

Volumn 140, Issue 3, 2011, Pages 643-651

  Sandiumenge, Alberto ^a   Lisboa, Thiago ^b   Gomez, Frederic ^a   Hernandez, Pilar ^a   Canadell, Laura ^a   Rello, Jordi ^c  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOXACILLIN; LINEZOLID; MACROLIDE; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPECIES DIVERSITY; STAPHYLOCOCCUS AUREUS; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 80052647822     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0462     Document Type: Article

References (25)

1. Giske CG, Monnet DL, Cars O, Carmeli Y; ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813-821. (Pubitemid 351358357)
2. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079-1081. (Pubitemid 351590040)
3. Dellit TH, Owens RC, McGowan JE Jr, et al Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177. (Pubitemid 46084814)
4. Zillich AJ, Sutherland JM, Wilson SJ, et al. Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol. 2006;27(10):1088-1095. (Pubitemid 44670986)
5. George P, Morris AM. Pro/con debate: should antimicrobial stewardship programs be adopted universally in the intensive care unit? Crit Care. 2010;14(1):205.
6. Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A. 2000;97(4):1938-1943. (Pubitemid 30118547)
7. Bonhoeffer MJ, Lipsitch M, Levin BR. Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci U S A. 1997;94(22):12106- 12111. (Pubitemid 27467850)
8. Bergstrom CT, Lo M, Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A. 2004;101(36):13285-13290. (Pubitemid 39209657)
9. Sandiumenge A, Diaz E, Rodriguez A, et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother. 2006;57(6):1197-1204. (Pubitemid 44644425)
10. Vidaur L, Sirgo G, Rodríguez AH, Rello J. Clinical approach to the patient with suspected ventilator-associated pneumonia. Respir Care. 2005;50(7):965-974. (Pubitemid 46196684)
11. Anguera Saperas L, Aragonés Mestre M, March Jardí M, et al. New strategy of actuation in central venous catheter and its influence in infection [in Spanish]. Enferm Intensiva. 2004;15(1):11-16.
12. Vidaur L, Gualis B, Rodriguez A, et al. Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome. Crit Care Med. 2005;33(6):1248-1253. (Pubitemid 40827373)
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-140.
14. Raineri E, Crema L, Dal Zoppo S, et al. Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Eur J Clin Microbiol Infect Dis. 2010;29(8):1015-1024.
15. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156(4 pt 1):1040-1048.
16. Gruson D, Hilbert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med. 2000;162(3 pt 1):837-843.
17. Warren DK, Hill HA, Merz LR, et al. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Crit Care Med. 2004;32(12):2450-2456. (Pubitemid 39648227)
18. Van Loon HJ, Vriens MR, Fluit AC, et al. Antibiotic rotation and development of gram-negative antibiotic resistance. Am J Respir Crit Care Med. 2005;171(5):480-487. (Pubitemid 40444248)
19. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14) 1233-1237. (Pubitemid 28469228)
20. Burke JP. Antibiotic resistance - squeezing the balloon? JAMA. 1998;280(14):1270-1271.
21. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1-12.
22. Rello J, Ausina V, Castella J, Net A, Prats G. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest. 1992;102(2):525-529.
23. Álvarez-Lerma F, Palomar M, Olaechea P, Otal JJ, Insausti J, Cerdá E; Grupo de Estudio de Vigilacia de Infección Nosocomial en UCI. National Study of Control of Nosocomial Infection in Intensive Care Units. Evolutive report of the years 2003-2005 [in Spanish]. Med Intensiva. 2007;31(1):6-17.
24. Koulenti D, Lisboa T, Brun-Buisson C, et al EU-VAP/CAP Study Group. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med. 2009;37(8):2360-2368.
25. Takesue Y, Nakajima K, Ichiki K, et al. Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria. J Hosp Infect. 2010;75(1):28-32.